siRNA therapy decreases triglycerides in individuals along with rare ailment

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran lessened triglyceride levels by 80% and lowered the risk of pancreatitis in individuals along with chronic chylomicronemia, along with or without a hereditary prognosis.